SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-21-000144
Filing Date
2021-08-04
Accepted
2021-08-04 15:20:09
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 6-30-2021 form10q.htm   iXBRL 10-Q 1936315
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 18665
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12847
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12724
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 6572
  Complete submission text file 0000874015-21-000144.txt   9455923

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20210630.xsd EX-101.SCH 51509
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20210630_cal.xml EX-101.CAL 68019
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20210630_def.xml EX-101.DEF 359401
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20210630_lab.xml EX-101.LAB 817683
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20210630_pre.xml EX-101.PRE 476647
11 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1848616
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 211143739
SIC: 2834 Pharmaceutical Preparations